The Pyruvate Kinase (PK) Activator AG-946 Improves PK Properties and Red Blood Cell (RBC) Characteristics upon <i>Ex Vivo</i> treatment of RBCs from Patients with Myelodysplastic Syndromes
Jonathan R.A. de Wilde(Utrecht University), Minke A.E. Rab(Utrecht University), Anna van Rhenen(Amsterdam UMC Location Vrije Universiteit Amsterdam), Noortje Thielen(Amsterdam UMC Location Vrije Universiteit Amsterdam), Wouter W. van Solinge(Utrecht University), Richard van Wijk(Utrecht University), Judith Jans(University Medical Center Utrecht), Brigitte A. van Oirschot(Utrecht University), Titine J.J. Ruiter(Utrecht University), Megan Wind‐Rotolo(Bristol-Myers Squibb (United States)), Lenny Dang(Millennium Engineering and Integration (United States))
Cited by 1
Related Papers
Interplay of somatic alterations and immune infiltration modulates response to PD-1 blockade in advanced clear cell renal cell carcinoma
|Nature Medicine|2020|1k
Frequent Engagement of the Classical and Alternative NF-κB Pathways by Diverse Genetic Abnormalities in Multiple Myeloma
|Cancer Cell|2007|949
AG-221, a First-in-Class Therapy Targeting Acute Myeloid Leukemia Harboring Oncogenic <i>IDH2</i> Mutations
|Cancer Discovery|2017|457